通过模仿血小板, 新的微凝可减少婴儿在手术期间出血. New microgel reduces infant bleeding during surgery by mimicking platelets.

生物医学工程师开发了一种可注射的微凝, Biomedical engineers have developed an injectable microgel designed to reduce bleeding in infants during surgery. 婴儿的血液与成年人的血有不同的凝固过程, 通常输血会导致危险的血栓. Unlike adult blood, infant blood has a different clotting process, and standard transfusions can cause dangerous blood clots. 早期测试显示,新型微凝模仿天然血小板并增强血液的结块性,减少了50%至60%的流血. The new microgels mimic natural platelets and enhance clotting, showing a 50% to 60% reduction in blood loss in early tests. 虽然这项技术很有前途, 但仍处于临床前阶段, 还没有准备好用于人类. While promising, the technology is still in preclinical stages and not yet ready for human use.